查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866859

人工智慧在藥物研發中的應用：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Artificial Intelligence in Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 162 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球人工智慧藥物開發市場規模估計為 22.81 億美元，預計到 2031 年將達到 145.11 億美元，在預測期（2025-2031 年）內複合年成長率為 30.7%。

醫療保健領域的人工智慧技術利用機器學習模型搜尋醫療數據，並從中提取洞見，從而改善健康結果並提升患者體驗。電腦科學和資訊科學的最新進展使人工智慧 (AI) 成為現代醫療保健不可或缺的一部分。人工智慧演算法和其他人工智慧驅動的應用正被用於輔助醫療專業進行臨床工作和持續研究。目前，人工智慧在醫療保健領域最常見的應用是臨床決策支援和影像分析。臨床決策支援工具透過提供相關的病患資訊和研究數據，幫助醫療服務提供者就治療方案、藥物、心理健康和其他病患需求做出決策。藥物研發是藥物開發過程中耗時最長、高成本的環節之一。人工智慧可以透過兩種主要方式降低新藥研發成本：一是最佳化藥物設計，二是發現有前景的新藥組合。利用人工智慧有望克服生命科學產業面臨的諸多巨量資料挑戰。

人工智慧（AI）在藥物研發領域的市場成長，源自於加速開發新型療法並降低成本的迫切需求。傳統的藥物研發流程往往耗時費力、成本高且失敗率高。人工智慧能夠快速識別候選藥物、預測藥物-標靶交互作用並最佳化臨床試驗設計，從而顯著縮短研發週期。生物醫學數據的爆炸性成長，包括基因組學、蛋白質組學和真實世界臨床資料集，為人工智慧演算法發現新見解提供了沃土。此外，製藥公司、生技公司和創業投資對人工智慧驅動平台的投資不斷增加，加上深度學習、自然語言處理和生成模型技術的進步，都在推動人工智慧的應用。監管機構對人工智慧驅動的藥物研發工作流程的開放態度，也為這一變革性領域的成長提供了支持。

本報告旨在對全球人工智慧在藥物發現領域的市場進行全面分析，依地區/國家、類型和應用進行分類，重點關注總收入、市場佔有率和主要企業的排名。

本報告以收益為準，以2024年為基準年，對人工智慧在藥物研發領域的市場規模、估算和預測進行了闡述，並包含了2020年至2031年的歷史數據和預測數據。報告運用定量和定性分析相結合的方法，幫助讀者制定業務/成長策略，評估競爭格局，分析公司在當前市場中的地位，並就人工智慧在藥物研發領域的應用做出明智的商業決策。

市場區隔

公司

  • IBM
  • Exscientia
  • Google（Alphabet）
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals, Inc

依類型分類的區隔市場

  • 硬體
  • 軟體
  • 服務

應用領域

  • 早期藥物發現
  • 臨床前階段
  • 臨床階段
  • 監管部門核准

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14511 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.

Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient. Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.

The market for artificial intelligence (AI) in drug discovery is driven by the urgent need to accelerate and reduce the cost of developing new therapeutics, as traditional drug discovery is often slow, expensive, and prone to high failure rates. AI enables rapid identification of drug candidates, predictive modeling of drug-target interactions, and optimization of clinical trial design, significantly shortening development timelines. The explosion of biomedical data, including genomics, proteomics, and real-world clinical datasets, provides a rich foundation for AI algorithms to uncover novel insights. Additionally, rising investment from pharmaceutical companies, biotech firms, and venture capital in AI-driven platforms-combined with advances in deep learning, natural language processing, and generative models-is propelling adoption. Regulatory agencies' increasing openness to AI-assisted drug development workflows also supports the growth of this transformative sector.

This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Drug Discovery, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence in Drug Discovery by region & country, by Type, and by Application.

The Artificial Intelligence in Drug Discovery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Drug Discovery.

Market Segmentation

By Company

  • IBM
  • Exscientia
  • Google(Alphabet)
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals, Inc

Segment by Type

  • Hardware
  • Software
  • Service

Segment by Application

  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Artificial Intelligence in Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Artificial Intelligence in Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Artificial Intelligence in Drug Discovery in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Artificial Intelligence in Drug Discovery Product Introduction
  • 1.2 Global Artificial Intelligence in Drug Discovery Market Size Forecast (2020-2031)
  • 1.3 Artificial Intelligence in Drug Discovery Market Trends & Drivers
    • 1.3.1 Artificial Intelligence in Drug Discovery Industry Trends
    • 1.3.2 Artificial Intelligence in Drug Discovery Market Drivers & Opportunity
    • 1.3.3 Artificial Intelligence in Drug Discovery Market Challenges
    • 1.3.4 Artificial Intelligence in Drug Discovery Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Artificial Intelligence in Drug Discovery Players Revenue Ranking (2024)
  • 2.2 Global Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025)
  • 2.3 Key Companies Artificial Intelligence in Drug Discovery Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Artificial Intelligence in Drug Discovery Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence in Drug Discovery
  • 2.6 Artificial Intelligence in Drug Discovery Market Competitive Analysis
    • 2.6.1 Artificial Intelligence in Drug Discovery Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence in Drug Discovery Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Drug Discovery as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Hardware
    • 3.1.2 Software
    • 3.1.3 Service
  • 3.2 Global Artificial Intelligence in Drug Discovery Sales Value by Type
    • 3.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Artificial Intelligence in Drug Discovery Sales Value, by Type (2020-2031)
    • 3.2.3 Global Artificial Intelligence in Drug Discovery Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Early Drug Discovery
    • 4.1.2 Preclinical Phase
    • 4.1.3 Clinical Phase
    • 4.1.4 Regulatory Approval
  • 4.2 Global Artificial Intelligence in Drug Discovery Sales Value by Application
    • 4.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Artificial Intelligence in Drug Discovery Sales Value, by Application (2020-2031)
    • 4.2.3 Global Artificial Intelligence in Drug Discovery Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Artificial Intelligence in Drug Discovery Sales Value by Region
    • 5.1.1 Global Artificial Intelligence in Drug Discovery Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Artificial Intelligence in Drug Discovery Sales Value by Region (2020-2025)
    • 5.1.3 Global Artificial Intelligence in Drug Discovery Sales Value by Region (2026-2031)
    • 5.1.4 Global Artificial Intelligence in Drug Discovery Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 5.2.2 North America Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 5.3.2 Europe Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Artificial Intelligence in Drug Discovery Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 5.5.2 South America Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.3.2 United States Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.4.2 Europe Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.5.2 China Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.6.2 Japan Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.7.2 South Korea Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
    • 6.9.2 India Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 IBM
    • 7.1.1 IBM Profile
    • 7.1.2 IBM Main Business
    • 7.1.3 IBM Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.1.4 IBM Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.1.5 IBM Recent Developments
  • 7.2 Exscientia
    • 7.2.1 Exscientia Profile
    • 7.2.2 Exscientia Main Business
    • 7.2.3 Exscientia Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.2.4 Exscientia Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Exscientia Recent Developments
  • 7.3 Google(Alphabet)
    • 7.3.1 Google(Alphabet) Profile
    • 7.3.2 Google(Alphabet) Main Business
    • 7.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Google(Alphabet) Recent Developments
  • 7.4 Microsoft
    • 7.4.1 Microsoft Profile
    • 7.4.2 Microsoft Main Business
    • 7.4.3 Microsoft Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.4.4 Microsoft Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Microsoft Recent Developments
  • 7.5 Atomwise
    • 7.5.1 Atomwise Profile
    • 7.5.2 Atomwise Main Business
    • 7.5.3 Atomwise Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.5.4 Atomwise Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Atomwise Recent Developments
  • 7.6 Schrodinger
    • 7.6.1 Schrodinger Profile
    • 7.6.2 Schrodinger Main Business
    • 7.6.3 Schrodinger Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.6.4 Schrodinger Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Schrodinger Recent Developments
  • 7.7 Aitia
    • 7.7.1 Aitia Profile
    • 7.7.2 Aitia Main Business
    • 7.7.3 Aitia Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.7.4 Aitia Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Aitia Recent Developments
  • 7.8 Insilico Medicine
    • 7.8.1 Insilico Medicine Profile
    • 7.8.2 Insilico Medicine Main Business
    • 7.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Insilico Medicine Recent Developments
  • 7.9 NVIDIA
    • 7.9.1 NVIDIA Profile
    • 7.9.2 NVIDIA Main Business
    • 7.9.3 NVIDIA Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.9.4 NVIDIA Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.9.5 NVIDIA Recent Developments
  • 7.10 XtalPi
    • 7.10.1 XtalPi Profile
    • 7.10.2 XtalPi Main Business
    • 7.10.3 XtalPi Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.10.4 XtalPi Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.10.5 XtalPi Recent Developments
  • 7.11 BPGbio
    • 7.11.1 BPGbio Profile
    • 7.11.2 BPGbio Main Business
    • 7.11.3 BPGbio Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.11.4 BPGbio Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.11.5 BPGbio Recent Developments
  • 7.12 Owkin
    • 7.12.1 Owkin Profile
    • 7.12.2 Owkin Main Business
    • 7.12.3 Owkin Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.12.4 Owkin Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Owkin Recent Developments
  • 7.13 CytoReason
    • 7.13.1 CytoReason Profile
    • 7.13.2 CytoReason Main Business
    • 7.13.3 CytoReason Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.13.4 CytoReason Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.13.5 CytoReason Recent Developments
  • 7.14 Deep Genomics
    • 7.14.1 Deep Genomics Profile
    • 7.14.2 Deep Genomics Main Business
    • 7.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Deep Genomics Recent Developments
  • 7.15 Cloud Pharmaceuticals
    • 7.15.1 Cloud Pharmaceuticals Profile
    • 7.15.2 Cloud Pharmaceuticals Main Business
    • 7.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Cloud Pharmaceuticals Recent Developments
  • 7.16 BenevolentAI
    • 7.16.1 BenevolentAI Profile
    • 7.16.2 BenevolentAI Main Business
    • 7.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.16.5 BenevolentAI Recent Developments
  • 7.17 Cyclica
    • 7.17.1 Cyclica Profile
    • 7.17.2 Cyclica Main Business
    • 7.17.3 Cyclica Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.17.4 Cyclica Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Cyclica Recent Developments
  • 7.18 Verge Genomics
    • 7.18.1 Verge Genomics Profile
    • 7.18.2 Verge Genomics Main Business
    • 7.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Verge Genomics Recent Developments
  • 7.19 Valo Health
    • 7.19.1 Valo Health Profile
    • 7.19.2 Valo Health Main Business
    • 7.19.3 Valo Health Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.19.4 Valo Health Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Valo Health Recent Developments
  • 7.20 Envisagenics
    • 7.20.1 Envisagenics Profile
    • 7.20.2 Envisagenics Main Business
    • 7.20.3 Envisagenics Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.20.4 Envisagenics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Envisagenics Recent Developments
  • 7.21 Euretos
    • 7.21.1 Euretos Profile
    • 7.21.2 Euretos Main Business
    • 7.21.3 Euretos Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.21.4 Euretos Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.21.5 Euretos Recent Developments
  • 7.22 BioAge Labs
    • 7.22.1 BioAge Labs Profile
    • 7.22.2 BioAge Labs Main Business
    • 7.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.22.5 BioAge Labs Recent Developments
  • 7.23 Iktos
    • 7.23.1 Iktos Profile
    • 7.23.2 Iktos Main Business
    • 7.23.3 Iktos Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.23.4 Iktos Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.23.5 Iktos Recent Developments
  • 7.24 BioSymetrics
    • 7.24.1 BioSymetrics Profile
    • 7.24.2 BioSymetrics Main Business
    • 7.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.24.5 BioSymetrics Recent Developments
  • 7.25 Evaxion Biotech
    • 7.25.1 Evaxion Biotech Profile
    • 7.25.2 Evaxion Biotech Main Business
    • 7.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.25.5 Evaxion Biotech Recent Developments
  • 7.26 Aria Pharmaceuticals, Inc
    • 7.26.1 Aria Pharmaceuticals, Inc Profile
    • 7.26.2 Aria Pharmaceuticals, Inc Main Business
    • 7.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Products, Services and Solutions
    • 7.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
    • 7.26.5 Aria Pharmaceuticals, Inc Recent Developments

8 Industry Chain Analysis

  • 8.1 Artificial Intelligence in Drug Discovery Industrial Chain
  • 8.2 Artificial Intelligence in Drug Discovery Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Artificial Intelligence in Drug Discovery Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Artificial Intelligence in Drug Discovery Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Artificial Intelligence in Drug Discovery Market Trends
  • Table 2. Artificial Intelligence in Drug Discovery Market Drivers & Opportunity
  • Table 3. Artificial Intelligence in Drug Discovery Market Challenges
  • Table 4. Artificial Intelligence in Drug Discovery Market Restraints
  • Table 5. Global Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Artificial Intelligence in Drug Discovery Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Artificial Intelligence in Drug Discovery Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Artificial Intelligence in Drug Discovery
  • Table 10. Global Artificial Intelligence in Drug Discovery Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Drug Discovery as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Artificial Intelligence in Drug Discovery Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Artificial Intelligence in Drug Discovery Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Artificial Intelligence in Drug Discovery Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Artificial Intelligence in Drug Discovery Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Artificial Intelligence in Drug Discovery Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Artificial Intelligence in Drug Discovery Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Artificial Intelligence in Drug Discovery Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Artificial Intelligence in Drug Discovery Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Artificial Intelligence in Drug Discovery Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Artificial Intelligence in Drug Discovery Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Artificial Intelligence in Drug Discovery Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Artificial Intelligence in Drug Discovery Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Artificial Intelligence in Drug Discovery Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Artificial Intelligence in Drug Discovery Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Artificial Intelligence in Drug Discovery Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value, (2026-2031) & (US$ Million)
  • Table 31. IBM Basic Information List
  • Table 32. IBM Description and Business Overview
  • Table 33. IBM Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of IBM (2020-2025)
  • Table 35. IBM Recent Developments
  • Table 36. Exscientia Basic Information List
  • Table 37. Exscientia Description and Business Overview
  • Table 38. Exscientia Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Exscientia (2020-2025)
  • Table 40. Exscientia Recent Developments
  • Table 41. Google(Alphabet) Basic Information List
  • Table 42. Google(Alphabet) Description and Business Overview
  • Table 43. Google(Alphabet) Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Google(Alphabet) (2020-2025)
  • Table 45. Google(Alphabet) Recent Developments
  • Table 46. Microsoft Basic Information List
  • Table 47. Microsoft Description and Business Overview
  • Table 48. Microsoft Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Microsoft (2020-2025)
  • Table 50. Microsoft Recent Developments
  • Table 51. Atomwise Basic Information List
  • Table 52. Atomwise Description and Business Overview
  • Table 53. Atomwise Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Atomwise (2020-2025)
  • Table 55. Atomwise Recent Developments
  • Table 56. Schrodinger Basic Information List
  • Table 57. Schrodinger Description and Business Overview
  • Table 58. Schrodinger Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Schrodinger (2020-2025)
  • Table 60. Schrodinger Recent Developments
  • Table 61. Aitia Basic Information List
  • Table 62. Aitia Description and Business Overview
  • Table 63. Aitia Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Aitia (2020-2025)
  • Table 65. Aitia Recent Developments
  • Table 66. Insilico Medicine Basic Information List
  • Table 67. Insilico Medicine Description and Business Overview
  • Table 68. Insilico Medicine Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Insilico Medicine (2020-2025)
  • Table 70. Insilico Medicine Recent Developments
  • Table 71. NVIDIA Basic Information List
  • Table 72. NVIDIA Description and Business Overview
  • Table 73. NVIDIA Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of NVIDIA (2020-2025)
  • Table 75. NVIDIA Recent Developments
  • Table 76. XtalPi Basic Information List
  • Table 77. XtalPi Description and Business Overview
  • Table 78. XtalPi Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of XtalPi (2020-2025)
  • Table 80. XtalPi Recent Developments
  • Table 81. BPGbio Basic Information List
  • Table 82. BPGbio Description and Business Overview
  • Table 83. BPGbio Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of BPGbio (2020-2025)
  • Table 85. BPGbio Recent Developments
  • Table 86. Owkin Basic Information List
  • Table 87. Owkin Description and Business Overview
  • Table 88. Owkin Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Owkin (2020-2025)
  • Table 90. Owkin Recent Developments
  • Table 91. CytoReason Basic Information List
  • Table 92. CytoReason Description and Business Overview
  • Table 93. CytoReason Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of CytoReason (2020-2025)
  • Table 95. CytoReason Recent Developments
  • Table 96. Deep Genomics Basic Information List
  • Table 97. Deep Genomics Description and Business Overview
  • Table 98. Deep Genomics Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Deep Genomics (2020-2025)
  • Table 100. Deep Genomics Recent Developments
  • Table 101. Cloud Pharmaceuticals Basic Information List
  • Table 102. Cloud Pharmaceuticals Description and Business Overview
  • Table 103. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Cloud Pharmaceuticals (2020-2025)
  • Table 105. Cloud Pharmaceuticals Recent Developments
  • Table 106. BenevolentAI Basic Information List
  • Table 107. BenevolentAI Description and Business Overview
  • Table 108. BenevolentAI Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of BenevolentAI (2020-2025)
  • Table 110. BenevolentAI Recent Developments
  • Table 111. Cyclica Basic Information List
  • Table 112. Cyclica Description and Business Overview
  • Table 113. Cyclica Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Cyclica (2020-2025)
  • Table 115. Cyclica Recent Developments
  • Table 116. Verge Genomics Basic Information List
  • Table 117. Verge Genomics Description and Business Overview
  • Table 118. Verge Genomics Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Verge Genomics (2020-2025)
  • Table 120. Verge Genomics Recent Developments
  • Table 121. Valo Health Basic Information List
  • Table 122. Valo Health Description and Business Overview
  • Table 123. Valo Health Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Valo Health (2020-2025)
  • Table 125. Valo Health Recent Developments
  • Table 126. Envisagenics Basic Information List
  • Table 127. Envisagenics Description and Business Overview
  • Table 128. Envisagenics Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 129. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Envisagenics (2020-2025)
  • Table 130. Envisagenics Recent Developments
  • Table 131. Euretos Basic Information List
  • Table 132. Euretos Description and Business Overview
  • Table 133. Euretos Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 134. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Euretos (2020-2025)
  • Table 135. Euretos Recent Developments
  • Table 136. BioAge Labs Basic Information List
  • Table 137. BioAge Labs Description and Business Overview
  • Table 138. BioAge Labs Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 139. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of BioAge Labs (2020-2025)
  • Table 140. BioAge Labs Recent Developments
  • Table 141. Iktos Basic Information List
  • Table 142. Iktos Description and Business Overview
  • Table 143. Iktos Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 144. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Iktos (2020-2025)
  • Table 145. Iktos Recent Developments
  • Table 146. BioSymetrics Basic Information List
  • Table 147. BioSymetrics Description and Business Overview
  • Table 148. BioSymetrics Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 149. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of BioSymetrics (2020-2025)
  • Table 150. BioSymetrics Recent Developments
  • Table 151. Evaxion Biotech Basic Information List
  • Table 152. Evaxion Biotech Description and Business Overview
  • Table 153. Evaxion Biotech Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 154. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Evaxion Biotech (2020-2025)
  • Table 155. Evaxion Biotech Recent Developments
  • Table 156. Aria Pharmaceuticals, Inc Basic Information List
  • Table 157. Aria Pharmaceuticals, Inc Description and Business Overview
  • Table 158. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Products, Services and Solutions
  • Table 159. Revenue (US$ Million) in Artificial Intelligence in Drug Discovery Business of Aria Pharmaceuticals, Inc (2020-2025)
  • Table 160. Aria Pharmaceuticals, Inc Recent Developments
  • Table 161. Key Raw Materials Lists
  • Table 162. Raw Materials Key Suppliers Lists
  • Table 163. Artificial Intelligence in Drug Discovery Downstream Customers
  • Table 164. Artificial Intelligence in Drug Discovery Distributors List
  • Table 165. Research Programs/Design for This Report
  • Table 166. Key Data Information from Secondary Sources
  • Table 167. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Artificial Intelligence in Drug Discovery Product Picture
  • Figure 2. Global Artificial Intelligence in Drug Discovery Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Artificial Intelligence in Drug Discovery Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Artificial Intelligence in Drug Discovery Report Years Considered
  • Figure 5. Global Artificial Intelligence in Drug Discovery Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Artificial Intelligence in Drug Discovery Revenue in 2024
  • Figure 7. Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Hardware Picture
  • Figure 9. Software Picture
  • Figure 10. Service Picture
  • Figure 11. Global Artificial Intelligence in Drug Discovery Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Artificial Intelligence in Drug Discovery Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Early Drug Discovery
  • Figure 14. Product Picture of Preclinical Phase
  • Figure 15. Product Picture of Clinical Phase
  • Figure 16. Product Picture of Regulatory Approval
  • Figure 17. Global Artificial Intelligence in Drug Discovery Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global Artificial Intelligence in Drug Discovery Sales Value Market Share by Application, 2024 & 2031
  • Figure 19. North America Artificial Intelligence in Drug Discovery Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific Artificial Intelligence in Drug Discovery Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value (%), (2020-2031)
  • Figure 30. United States Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Europe Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 36. China Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Japan Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 42. South Korea Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Southeast Asia Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 48. India Artificial Intelligence in Drug Discovery Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India Artificial Intelligence in Drug Discovery Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Artificial Intelligence in Drug Discovery Industrial Chain
  • Figure 52. Artificial Intelligence in Drug Discovery Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed